Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis

MeSH terms

• Aged
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Agents / therapeutic use*
• Female
• Humans
• Lymphocytes / drug effects*
• Lymphoma, B-Cell, Marginal Zone / complications
• Lymphoma, B-Cell, Marginal Zone / drug therapy*
• Renal Dialysis
• Rituximab
• Splenic Neoplasms / complications
• Splenic Neoplasms / drug therapy*